-
1
-
-
0038545837
-
Calcific aortic stenosis: from bench to the bedside-emerging clinical and cellular concepts
-
Rajamannan N.M., Gersh B., and Bonow R.O. Calcific aortic stenosis: from bench to the bedside-emerging clinical and cellular concepts. Heart 89 7 (2003) 801-805
-
(2003)
Heart
, vol.89
, Issue.7
, pp. 801-805
-
-
Rajamannan, N.M.1
Gersh, B.2
Bonow, R.O.3
-
2
-
-
0032936072
-
Presence of oxidized low density lipoprotein in nonrheumatic stenotic aortic valves
-
Olsson M., Thyberg J., and Nilsson J. Presence of oxidized low density lipoprotein in nonrheumatic stenotic aortic valves. Arterioscler Thromb Vasc Biol 19 5 (1999) 1218-1222
-
(1999)
Arterioscler Thromb Vasc Biol
, vol.19
, Issue.5
, pp. 1218-1222
-
-
Olsson, M.1
Thyberg, J.2
Nilsson, J.3
-
3
-
-
0027991976
-
Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies
-
Otto C.M., Kuusisto J., Reichenbach D.D., Gown A.M., and O'Brien K.D. Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies. Circulation 90 2 (1994) 844-853
-
(1994)
Circulation
, vol.90
, Issue.2
, pp. 844-853
-
-
Otto, C.M.1
Kuusisto, J.2
Reichenbach, D.D.3
Gown, A.M.4
O'Brien, K.D.5
-
4
-
-
24644510707
-
Atorvastatin inhibits hypercholesterolemia-induced calcification in the aortic valves via the Lrp5 receptor pathway
-
Rajamannan N.M., Subramaniam M., Caira F., Stock S.R., and Spelsberg T.C. Atorvastatin inhibits hypercholesterolemia-induced calcification in the aortic valves via the Lrp5 receptor pathway. Circulation 112 9 Suppl (2005) I229-I234
-
(2005)
Circulation
, vol.112
, Issue.9 SUPPL
-
-
Rajamannan, N.M.1
Subramaniam, M.2
Caira, F.3
Stock, S.R.4
Spelsberg, T.C.5
-
5
-
-
33646466212
-
Human degenerative valve disease is associated with up-regulation of low-density lipoprotein receptor-related protein 5 receptor-mediated bone formation
-
Caira F.C., Stock S.R., Gleason T.G., et al. Human degenerative valve disease is associated with up-regulation of low-density lipoprotein receptor-related protein 5 receptor-mediated bone formation. J Am Coll Cardiol 47 8 (2006) 1707-1712
-
(2006)
J Am Coll Cardiol
, vol.47
, Issue.8
, pp. 1707-1712
-
-
Caira, F.C.1
Stock, S.R.2
Gleason, T.G.3
-
6
-
-
4043080645
-
Hyperlipidaemia and aortic valve disease
-
Rossebo A.B., and Pedersen T.R. Hyperlipidaemia and aortic valve disease. Curr Opin Lipidol 15 4 (2004) 447-451
-
(2004)
Curr Opin Lipidol
, vol.15
, Issue.4
, pp. 447-451
-
-
Rossebo, A.B.1
Pedersen, T.R.2
-
7
-
-
0031051128
-
Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study
-
Stewart B.F., Siscovick D., Lind B.K., et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol 29 3 (1997) 630-634
-
(1997)
J Am Coll Cardiol
, vol.29
, Issue.3
, pp. 630-634
-
-
Stewart, B.F.1
Siscovick, D.2
Lind, B.K.3
-
8
-
-
0027477079
-
Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample
-
Lindroos M., Kupari M., Heikkila J., and Tilvis R. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol 21 5 (1993) 1220-1225
-
(1993)
J Am Coll Cardiol
, vol.21
, Issue.5
, pp. 1220-1225
-
-
Lindroos, M.1
Kupari, M.2
Heikkila, J.3
Tilvis, R.4
-
9
-
-
0029059364
-
Prevalence of dyslipidemic phenotypes in ischemic heart disease (prospective results from the Quebec Cardiovascular Study)
-
Lamarche B., Despres J.P., Moorjani S., Cantin B., Dagenais G.R., and Lupien P.J. Prevalence of dyslipidemic phenotypes in ischemic heart disease (prospective results from the Quebec Cardiovascular Study). Am J Cardiol 75 17 (1995) 1189-1195
-
(1995)
Am J Cardiol
, vol.75
, Issue.17
, pp. 1189-1195
-
-
Lamarche, B.1
Despres, J.P.2
Moorjani, S.3
Cantin, B.4
Dagenais, G.R.5
Lupien, P.J.6
-
10
-
-
0036182137
-
Lipotoxic diseases
-
Unger R.H. Lipotoxic diseases. Annu Rev Med 53 (2002) 319-336
-
(2002)
Annu Rev Med
, vol.53
, pp. 319-336
-
-
Unger, R.H.1
-
11
-
-
0036230922
-
Leptin resistance during aging is independent of fat mass
-
Gabriely I., Ma X.H., Yang X.M., Rossetti L., and Barzilai N. Leptin resistance during aging is independent of fat mass. Diabetes 51 4 (2002) 1016-1021
-
(2002)
Diabetes
, vol.51
, Issue.4
, pp. 1016-1021
-
-
Gabriely, I.1
Ma, X.H.2
Yang, X.M.3
Rossetti, L.4
Barzilai, N.5
-
12
-
-
33646806826
-
Lipotoxicity, overnutrition and energy metabolism in aging
-
Slawik M., and Vidal-Puig A.J. Lipotoxicity, overnutrition and energy metabolism in aging. Ageing Res Rev 5 2 (2006) 144-164
-
(2006)
Ageing Res Rev
, vol.5
, Issue.2
, pp. 144-164
-
-
Slawik, M.1
Vidal-Puig, A.J.2
-
13
-
-
29144432822
-
Resistin is secreted from macrophages in atheromas and promotes atherosclerosis
-
Jung H.S., Park K.H., Cho Y.M., et al. Resistin is secreted from macrophages in atheromas and promotes atherosclerosis. Cardiovasc Res 69 1 (2006) 76-85
-
(2006)
Cardiovasc Res
, vol.69
, Issue.1
, pp. 76-85
-
-
Jung, H.S.1
Park, K.H.2
Cho, Y.M.3
-
14
-
-
1842506529
-
The current biology of resistin
-
Steppan C.M., and Lazar M.A. The current biology of resistin. J Intern Med 255 4 (2004) 439-447
-
(2004)
J Intern Med
, vol.255
, Issue.4
, pp. 439-447
-
-
Steppan, C.M.1
Lazar, M.A.2
-
15
-
-
14044257211
-
Resistin is an inflammatory marker of atherosclerosis in humans
-
Reilly M.P., Lehrke M., Wolfe M.L., Rohatgi A., Lazar M.A., and Rader D.J. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 111 7 (2005) 932-939
-
(2005)
Circulation
, vol.111
, Issue.7
, pp. 932-939
-
-
Reilly, M.P.1
Lehrke, M.2
Wolfe, M.L.3
Rohatgi, A.4
Lazar, M.A.5
Rader, D.J.6
-
16
-
-
0343851647
-
Segregation analysis of apolipoproteins A-1 and B-100 measured before and after an exercise training program: the HERITAGE Family Study
-
An P., Rice T., Gagnon J., et al. Segregation analysis of apolipoproteins A-1 and B-100 measured before and after an exercise training program: the HERITAGE Family Study. Arterioscler Thromb Vasc Biol 20 3 (2000) 807-814
-
(2000)
Arterioscler Thromb Vasc Biol
, vol.20
, Issue.3
, pp. 807-814
-
-
An, P.1
Rice, T.2
Gagnon, J.3
-
17
-
-
33746860419
-
Pathogenesis of calcific aortic valve disease: a disease process comes of age (and a good deal more)
-
O'Brien K.D. Pathogenesis of calcific aortic valve disease: a disease process comes of age (and a good deal more). Arterioscler Thromb Vasc Biol 26 8 (2006) 1721-1728
-
(2006)
Arterioscler Thromb Vasc Biol
, vol.26
, Issue.8
, pp. 1721-1728
-
-
O'Brien, K.D.1
-
18
-
-
33750844857
-
Distribution of SPARC during neovascularisation of degenerative aortic stenosis
-
Charest A., Pepin A., Shetty R., et al. Distribution of SPARC during neovascularisation of degenerative aortic stenosis. Heart 92 12 (2006) 1844-1849
-
(2006)
Heart
, vol.92
, Issue.12
, pp. 1844-1849
-
-
Charest, A.1
Pepin, A.2
Shetty, R.3
-
19
-
-
37549064021
-
Association between plasma LDL particle size, valvular accumulation of oxidized LDL, and inflammation in patients with aortic stenosis
-
Mohty D., Pibarot P., Despres J.P., et al. Association between plasma LDL particle size, valvular accumulation of oxidized LDL, and inflammation in patients with aortic stenosis. Arterioscler Thromb Vasc Biol 28 1 (2008) 187-193
-
(2008)
Arterioscler Thromb Vasc Biol
, vol.28
, Issue.1
, pp. 187-193
-
-
Mohty, D.1
Pibarot, P.2
Despres, J.P.3
-
20
-
-
0035667904
-
Reduced HDL particle size as an additional feature of the atherogenic dyslipidemia of abdominal obesity
-
Pascot A., Lemieux I., Prud'homme D., et al. Reduced HDL particle size as an additional feature of the atherogenic dyslipidemia of abdominal obesity. J Lipid Res 42 12 (2001) 2007-2014
-
(2001)
J Lipid Res
, vol.42
, Issue.12
, pp. 2007-2014
-
-
Pascot, A.1
Lemieux, I.2
Prud'homme, D.3
-
21
-
-
33645997399
-
The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy - a review of the evidence
-
Walldius G., and Jungner I. The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy - a review of the evidence. J Intern Med 259 5 (2006) 493-519
-
(2006)
J Intern Med
, vol.259
, Issue.5
, pp. 493-519
-
-
Walldius, G.1
Jungner, I.2
-
22
-
-
0142088521
-
Unique lipoprotein phenotype and genotype associated with exceptional longevity
-
Barzilai N., Atzmon G., Schechter C., et al. Unique lipoprotein phenotype and genotype associated with exceptional longevity. JAMA 290 15 (2003) 2030-2040
-
(2003)
JAMA
, vol.290
, Issue.15
, pp. 2030-2040
-
-
Barzilai, N.1
Atzmon, G.2
Schechter, C.3
-
23
-
-
0043164953
-
Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction
-
Verma S., Li S.H., Wang C.H., et al. Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation 108 6 (2003) 736-740
-
(2003)
Circulation
, vol.108
, Issue.6
, pp. 736-740
-
-
Verma, S.1
Li, S.H.2
Wang, C.H.3
-
24
-
-
0037022278
-
Monocyte/macrophage regulation of vascular calcification in vitro
-
Tintut Y., Patel J., Territo M., Saini T., Parhami F., and Demer L.L. Monocyte/macrophage regulation of vascular calcification in vitro. Circulation 105 5 (2002) 650-655
-
(2002)
Circulation
, vol.105
, Issue.5
, pp. 650-655
-
-
Tintut, Y.1
Patel, J.2
Territo, M.3
Saini, T.4
Parhami, F.5
Demer, L.L.6
-
25
-
-
0029872345
-
Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of 'degenerative' valvular aortic stenosis
-
O'Brien K.D., Reichenbach D.D., Marcovina S.M., Kuusisto J., Alpers C.E., and Otto C.M. Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of 'degenerative' valvular aortic stenosis. Arterioscler Thromb Vasc Biol 16 4 (1996) 523-532
-
(1996)
Arterioscler Thromb Vasc Biol
, vol.16
, Issue.4
, pp. 523-532
-
-
O'Brien, K.D.1
Reichenbach, D.D.2
Marcovina, S.M.3
Kuusisto, J.4
Alpers, C.E.5
Otto, C.M.6
-
26
-
-
23644442404
-
Age-related changes in aortic valve with emphasis on the relation between pressure loading and thickened leaflets of the aortic valves
-
Lin S.L., Liu C.P., Young S.T., Lin M., and Chiou C.W. Age-related changes in aortic valve with emphasis on the relation between pressure loading and thickened leaflets of the aortic valves. Int J Cardiol 103 3 (2005) 272-279
-
(2005)
Int J Cardiol
, vol.103
, Issue.3
, pp. 272-279
-
-
Lin, S.L.1
Liu, C.P.2
Young, S.T.3
Lin, M.4
Chiou, C.W.5
-
27
-
-
0034031788
-
Aging influences development and progression of early aortic atherosclerotic lesions in cholesterol-fed rabbits
-
Orlandi A., Marcellini M., and Spagnoli L.G. Aging influences development and progression of early aortic atherosclerotic lesions in cholesterol-fed rabbits. Arterioscler Thromb Vasc Biol 20 4 (2000) 1123-1136
-
(2000)
Arterioscler Thromb Vasc Biol
, vol.20
, Issue.4
, pp. 1123-1136
-
-
Orlandi, A.1
Marcellini, M.2
Spagnoli, L.G.3
-
28
-
-
20344364674
-
A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis
-
Cowell S.J., Newby D.E., Prescott R.J., et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med 352 23 (2005) 2389-2397
-
(2005)
N Engl J Med
, vol.352
, Issue.23
, pp. 2389-2397
-
-
Cowell, S.J.1
Newby, D.E.2
Prescott, R.J.3
-
29
-
-
33846593363
-
Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis
-
Moura L.M., Ramos S.F., Zamorano J.L., et al. Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis. J Am Coll Cardiol 49 5 (2007) 554-561
-
(2007)
J Am Coll Cardiol
, vol.49
, Issue.5
, pp. 554-561
-
-
Moura, L.M.1
Ramos, S.F.2
Zamorano, J.L.3
-
30
-
-
0037427540
-
Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators
-
Patel L., Buckels A.C., Kinghorn I.J., et al. Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem Biophys Res Commun 300 2 (2003) 472-476
-
(2003)
Biochem Biophys Res Commun
, vol.300
, Issue.2
, pp. 472-476
-
-
Patel, L.1
Buckels, A.C.2
Kinghorn, I.J.3
-
31
-
-
26244453309
-
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial
-
Dormandy J.A., Charbonnel B., Eckland D.J., et al. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. Lancet 366 9493 (2005) 1279-1289
-
(2005)
Lancet
, vol.366
, Issue.9493
, pp. 1279-1289
-
-
Dormandy, J.A.1
Charbonnel, B.2
Eckland, D.J.3
-
32
-
-
57549110416
-
Ethical authorship and publishing
-
Coats A.J. Ethical authorship and publishing. Int J Cardiol 131 (2009) 149-150
-
(2009)
Int J Cardiol
, vol.131
, pp. 149-150
-
-
Coats, A.J.1
|